文献速递妇产影像儿科影像技术与安全USMR

全外显子组测序作为结构异常胎儿临床检测的诊断辅助手段

Whole exome sequencing as a diagnostic adjunct to clinical testing in fetuses with structural abnormalities.
PubMed 文献 · Ultrasound Obstet Gynecol · 2018-01-01

本研究对2011年1月至2015年12月转诊的3949例超声和/或磁共振检出结构异常的胎儿依次行核型分析、染色体微阵列分析(CMA)和全外显子组测序(WES),核型异常率18.2%,核型正常者CMA致病性拷贝数变异检出率8.2%,CMA与核型均正常的196例中WES在47例(24%)检出可能致病的遗传变异。

要点

  • 核型分析异常率18.2%(720/3949),核型正常者CMA致病性拷贝数变异检出率8.2%(138/1680)。
  • CMA与核型均正常的196例胎儿中,WES检出可能致病遗传变异47例(24%)。
  • WES检出意义未明变异25/196例(12.8%),偶然发现率6.1%(12/196)。

核心结论

  • WES是识别核型分析与CMA结果均正常的结构异常胎儿致病遗传变异的有前景方法,该提高的诊断率有潜力改善妊娠临床管理并为受影响家庭的生育决策提供更好信息。

研究设计与样本

  • 对2011年1月至2015年12月转诊的3949例超声和/或磁共振检出结构异常的胎儿储存样本依次行核型分析、CMA和WES,分析三种技术的诊断率(总体、表型亚组及 trio 与仅先证者样本)。

诊断标准与关键数值

  • 核型分析异常率18.2%(720/3949)。
  • 核型正常胎儿中CMA致病性拷贝数变异检出率8.2%(138/1680)。
  • CMA与核型均正常的196例中WES检出可能致病遗传变异47例(24%)。
  • WES分子诊断率:胎儿-父母 trio 样本26.5%(13/49),仅先证者样本23.1%(34/147)。
  • WES意义未明变异检出率12.8%(25/196),其中仅先证者组15%(22/147),trio组6.1%(3/49);偶然发现率6.1%(12/196)。

临床应用与阅片要点

  • 对超声和/或磁共振检出结构异常且核型分析与CMA均正常的胎儿,WES可提供额外分子诊断信息(24%检出可能致病变异)。
  • trio样本与仅先证者样本的WES分子诊断率分别为26.5%和23.1%,意义未明变异检出率分别为6.1%和15%。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: To evaluate the diagnostic yield of prenatal whole exome sequencing (WES) for monogenic disorders in fetuses with structural malformations and normal results on cytogenetic testing, and to describe information on pathogenic variants that is provided by WES.

METHODS: Karyotyping, chromosomal microarray analysis (CMA) and WES were performed sequentially on stored samples from a cohort of 3949 pregnancies with fetal structural abnormalities detected on ultrasound and/or magnetic resonance imaging, referred between January 2011 and December 2015. Diagnostic rates of the three techniques were investigated overall, for phenotypic subgroups and for proband-only vs fetus-mother-father samples. Information on pathogenic variants was identified by WES.

RESULTS: Overall, 18.2% (720/3949) of fetuses had an abnormal karyotype. Pathogenic copy number variants were detected on CMA in 8.2% (138/1680) of fetuses that had a normal karyotype result. WES performed on a subgroup of 196 fetuses with normal CMA and karyotype results revealed the putative genetic variants responsible for the abnormal phenotypes in 47 cases (24%). The molecular diagnosis rates for fetus-mother-father and proband-only samples were 26.5% (13/49) and 23.1% (34/147), respectively. Variants of uncertain significance were detected in 12.8% (25/196) of fetuses, of which 22 were identified in the fetal proband-only group (15%; 22/147) and three in the fetus-mother-father group (6.1%; 3/49). The incidental finding rate was 6.1% (12/196).

CONCLUSIONS: WES is a promising method for the identification of genetic variants that cause structural abnormalities in fetuses with normal results on karyotyping and CMA. This enhanced diagnostic yield has the potential to improve the clinical management of pregnancies and to inform better the reproductive decisions of affected families. Copyright © 2017 ISUOG. Published by John Wiley & Sons Ltd.

来源:Ultrasound Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Fu F, Li R, Li Y, et al. Whole exome sequencing as a diagnostic adjunct to clinical testing in fetuses with structural abnormalities. Ultrasound Obstet Gynecol. 2018. PMID: 28976722. doi:10.1002/uog.18915

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。